Serum leptin levels and insulin resistance are associated with gallstone in overweight subjects

World Journal of Gastroenterology

Volumn 11, Issue 39, 2005, Pages 6182-6187

  Méndez Sánchez, Nahum ^a   Bermejo Martínez, Luisa B ^b   Viñals, Yolanda ^a   Chavez Tapia, Norberto C ^a   Graff, Irina Vander ^a   Ponciano Rodríguez, Guadalupe ^c   Ramos, Martha H ^a   Uribe, Misael ^a  

^a LIVER RESEARCH UNIT   (Mexico)

^b INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Cholesterol; Gallstones; Insulin resistance; Leptin; Obesity

Indexed keywords

INSULIN; LEPTIN; LIPID; LIPOPROTEIN;

ADULT; ARTICLE; BODY MASS; CALCULATION; CASE CONTROL STUDY; CHOLELITHIASIS; CONTROLLED STUDY; DIAGNOSTIC KIT; DIET RESTRICTION; FEMALE; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEXICO; OBESITY; PATHOGENESIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; UNIVERSITY HOSPITAL;

EID: 30644480725     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i39.6182     Document Type: Article

References (41)

1. Mantzoros CS. The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med 1999; 130: 671-680
2. Mabee TM, Meyer P, DenBesten L, Mason EE. The mechanism of increased gallstone formation in obese human subjects. Surgery 1976; 79: 460-468
3. Reuben A, Maton PN, Murphy GM, Dowling RH. Bile lipid secretion in obese and non-obese individuals with and without gallstones. Clin Sci 1985; 69: 71-79
4. Stahlberg D, Rudling M, Angelin B, Bjorkhem I, Forsell P, Nilsell K, Einarsson K. Hepatic cholesterol metabolism in human obesity. Hepatology 1997; 25: 1447-1450
5. Bennion LJ, Grundy SM. Effects of obesity and caloric intake on biliary lipid metabolism in man. J Clin Invest 1975; 56: 996-1011
6. Rohner-Jeanrenaud F, Jeanrenaud B. Obesity, leptin, and the brain. N Engl J Med 1996; 334: 324-325
7. Hickey MS, Israel RG, Gardiner SN, Considine RV, McCammon MR, Tyndall GL, Hournard JA, Marks RH, Caro JF. Gender differences in serum leptin levels in humans. Biochem Mol Med 1996; 59: 1-6
8. Duggirala R, Mitchell BD, Blangero J, Stem MP. Genetic determinants of variation in gallbladder disease in the Mexican-American population. Genet Epidemiol 1999; 16: 191-204
9. Ruhl CE, Everhart JE. Relationship of serum leptin concentration and other measures of adiposity with gallbladder disease. Hepatology 2001; 34: 877-883
10. Mendez-Sanchez N, Gonzalez V, King-Martinez AC, Sanchez H, Uribe M. Plasma leptin and the cholesterol saturation of bile are correlated in obese women after weight loss. J Nutr 2002; 132: 2195-2198
11. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentriffige. Clin Chem 1972; 18: 499-502
12. Packard CJ, Saito Y. Non-HDL cholesterol as a measure of atherosclerotic risk. J Atheroscler Thromb 2004; 11: 6-14
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
14. Obesity: preventing and managing the global epidemic: report of a WHO consultation. Technical report series / World Health Organization, 894. 2000, Geneva: World Health Organization. 253
15. Fredenrich A, Bayer P. Reverse cholesterol transport, high density lipoproteins and HDL cholesterol: recent data. Diabetes Metab 2003; 29: 201-205
16. Rader DJ. Regulation of reverse cholesterol transport and clinical implications. Am J Cardiol 2003; 92: 42J-49J
17. Van Patten S, Ranginani N, Shefer S, Nguyen LB, Rossetti L, Cohen DE. Impaired biliary lipid secretion in obese Zucker rats: leptin promotes hepatic cholesterol clearance. Am J Physiol Gastrointest Liver Physiol 2001; 281: G393-404
18. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-295
19. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995; 1: 1155-1161
20. Hyogo H, Roy S, Paigen B, Cohen DE. Leptin promotes biliary cholesterol elimination during weight loss in ob/ob mice by regulating the enterohepatic circulation of bile salts. J Biol Chem 2002; 277: 34117-34124
21. Hyogo H, Roy S, Cohen DE. Restoration of gallstone susceptibility by leptin in C57BL/6J ob/ob mice. J Lipid Res 2003; 44: 1232-1240
22. Mendez-Sanchez N, Chavez-Tapia NC, Motola-Kuba D, Sanchez-Lara K, González V, Ponciano-Rodríguez G, Baptista H, Ramos MH, Uribe M. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol 2005; 11: 1653-1657
23. Scragg RK, Calvert GD, Oliver JR. Plasma lipids and insulin in gall stone disease: a case-control study. Br Med J 1984; 289: 521-525
24. Laakso M, Suhonen M, Julkunen R, Pyorala K. Plasma insulin, serum lipids and lipoproteins in gall stone disease in non-insulin dependent diabetic subjects: a case control study. Gut 1990; 31: 344-347
25. Haffner SM, Diehl AK, Mitchell BD, Stem MP, Hazuda HP. Increased prevalence of clinical gallbladder disease in subjects with non-insulin-dependent diabetes mellitus. Am J Epidemiol 1990; 132: 327-335
26. Gonzalez Villalpando C, Rivera Martinez D, Arredondo Perez B, Martinez Diaz S, Gonzalez Villalpando ME, Haffner SM, Stern MP. High prevalence of cholelithiasis in a low income Mexican population: an ultrasonographic survey. Arch Med Res 1997; 28: 543-547
27. Ruhl CE, Everhart JE. Association of diabetes, serum insulin, and C-peptide with gallbladder disease. Hepatology 2000; 31: 299-303
28. Nepokroeff CM, Lakshmanan MR, Ness GC, Dugan RE, Porter JW. Regulation of the diurnal rhythm of rat liver beta-hydroxy-beta-methylglutaryl coenzmye A reductase activity by insulin, glucagon, cyclic AMP and hydrocortisone. Arch Biochem Biophys 1974; 160: 387-396
29. Osborne AR, Pollock VV, Lagor WR, Ness GC. Identification of insulin-responsive regions in the HMG-CoA reductase promoter. Biochem Biophys Res Commun 2004; 318: 814-818
30. Chait A, Bierman EL, Albers JJ. Low-density lipoprotein receptor activity in cultured human skin fibroblasts. Mechanism of insulin-induced stimulation. J Clin Invest 1979; 64: 1309-1319
31. Gielkens HA, Lam WF, Coenraad M, Frolich M, van Oostayen JA, Lamers CB, Masclee AA. Effect of insulin on basal and cholecystokinin-stimulated gallbladder motility in humans. J Hepatol 1998; 28: 595-602
32. Goldblatt MI, Swartz-Basile DA, Svatek CL, Nakeeb A, Pitt HA. Decreased gallbladder response in leptin-deficient obese mice. J Gastrointest Surg 2002; 6: 438-442
33. Tran KQ, Goldblatt MI, Swartz-Basile DA, Svatek C, Nakeeb A, Pitt HA. Diabetes and hyperlipidemia correlate with gallbladder contractility in leptin-related murine obesity. J Gastrointest Surg 2003; 7: 857-862
34. Tran KQ, Swartz-Basile DA, Nakeeb A, Pitt HA. Gallbladder motility in agouti-yellow and leptin-resistant obese mice. J Surg Res 2003; 113: 56-61
35. Wauters M, Mertens I, Chagnon M, Rankinen T, Considine RV, Chagnon YC, Van Gaal LF, Bouchard C. Polymorphisms in the leptin receptor gene, body composition and fat distribution in overweight and obese women. Int J Obes Relat Metab Disord 2001; 25: 714-720
36. Tungtrongchitr R, Pongpaew P, Phonrat B, Tribunyatkul S, Viroonudomphol D, Supawan V, Jintandhi P, Lertchavanakul A, Vudhivai N, Schelp FP. Serum leptin and lipid profiles in Thai obese and overweight subjects. Int J Vitam Nutr Res 2001; 71: 74-81
37. Marinari GM, Scopinaro N, Adami GF. Leptin and HDL-cholesterol in non-diabetic normotensive subjects. Obes Surg 2001; 11: 252-253
38. Remsberg KE, Talbott EO, Zborowski JV, Evans RW, McHugh-Pemu K. Evidence for competing effects of body mass, hyperinsulinemia, insulin resistance, and androgens on leptin levels among lean, overweight, and obese women with polycystic ovary syndrome. Fertil Steril 2002; 78: 479-486
39. Silha JV, Krsek M, Hana V, Marek J, Jezkova J, Weiss V, Murphy LJ. Perturbations in adiponectin, leptin and resistin levels in acromegaly: lack of correlation with insulin resistance. Clin Endocrinol 2003; 58: 736-742
40. Wauters M, Considine RV, Yudkin JS, Peiffer F, De Leeuw I, Van Gaal LF. Leptin levels in type 2 diabetes: associations with measures of insulin resistance and insulin secretion. Horm Metab Res 2003; 35: 92-96
41. Ceddia RB, Koistinen HA, Zierath JR, Sweeney G. Analysis of paradoxical observations on the association between leptin and insulin resistance. Faseb J 2002; 16: 1163-1176